©The Author(s) 2021.
World J Gastrointest Surg. Mar 27, 2021; 13(3): 267-278
Published online Mar 27, 2021. doi: 10.4240/wjgs.v13.i3.267
Published online Mar 27, 2021. doi: 10.4240/wjgs.v13.i3.267
Table 8 Influence factors and assignments for neoadjuvant therapy effectiveness
| Factor | Variable | Assignment |
| Gender | X1 | M = 1, F = 0 |
| Age | X2 | ≤ 60 yr = 1, > 60 yr = 0 |
| Hypertension | X3 | N = 1, Y = 0 |
| Diabetes mellitus | X4 | N = 1, Y = 0 |
| Pre-operative radiation | X5 | N = 1, Y = 0 |
| Pre-T stage | X6 | T3 = 1, T4 = 0 |
| Tumor lower edge | X7 | ≤ 5 cm = 1, > 5 cm = 0 |
| TRG-0 or 1 | Y | Y = 1, N = 0 |
- Citation: Li WC, Zhao JK, Feng WQ, Miao YM, Xu ZF, Xu ZQ, Gao H, Sun J, Zheng MH, Zong YP, Lu AG. Retrospective research of neoadjuvant therapy on tumor-downstaging, post-operative complications, and prognosis in locally advanced rectal cancer. World J Gastrointest Surg 2021; 13(3): 267-278
- URL: https://www.wjgnet.com/1948-9366/full/v13/i3/267.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i3.267